Largest, most representative PsA data registry available for licensing, analytics, and collaboration
Research-Grade RWD in PsA
Disease with no cure
With no cure for PsA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.
Deep Clinical Data
PsA patients followed prospectively with deep clinical, lab, and other linked data
*Counts complete through Q2 2023
Analytics & Modeling
PsA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes
Why OM1 PsA?
Sample Use Cases
» Comparative Effectiveness
» Passive Safety
» Natural History
Interested in exploring Psoriasis patients too?
Check out our Dermatology network
Abstracts & Posters
Poster (AAD 2023): Patient-Reported Outcomes and Changes in DMARD Therapy Among Psoriatic Arthritis Patients Treated in Routine Clinical Practice
Poster (AAD 2023): Comparison of Improvements in Psoriatic Arthritis Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real-World Cohort